Fifteen years in the making, biotech lands in Bay Area with fresh funding from Hyatt heirs and plan to change direction of inflammatory diseases

Giant drug maker Bristol-Myers Squibb and a string of investment vehicles led by heirs of the Hyatt Hotels fortune invested in a North Bay company tapping deep patient data to move faster to discover and develop drugs against lupus, Crohn's disease and other inflammatory diseases.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news